Over-the-counter Narcan gets unanimous thumbs-up from FDA advisors
Emergent BioSolutions is getting closer to an approval for over-the-counter Narcan. On Wednesday, the FDA’s combined advisory committees for Nonprescription Drug and Anesthetic, and Analgesic Drug Products, voted 19-0 in favor of the company’s proposed OTC Narcan 4-mg nasal spray.
“The benefits clearly outweigh the risks and the urgency is definitely paramount. I actually had a friend who lost her 19-year-old son about four days ago,” said committee member Michael Sprintz, clinical assistant professor at University of Texas Health Science Center Houston. “I think this is a wonderful thing we did today.”
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.